What is Merrimack Pharmaceuticals, Inc.'s current stock price?

Merrimack Pharmaceuticals, Inc. (MACK) currently trades at USD 15.15. Track real-time price changes and historical performance on AllInvestView.

What is Merrimack Pharmaceuticals, Inc.'s dividend yield?

Merrimack Pharmaceuticals, Inc. has a dividend yield of 99.70300000%. Track dividend payments and income with AllInvestView.

What sector is Merrimack Pharmaceuticals, Inc. in?

Merrimack Pharmaceuticals, Inc. operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

Merrimack Pharmaceuticals, Inc. MACK · Stock Open Merrimack Pharmaceuticals, Inc. in new tab

15.15 USD

Add to portfolio

Yield

99.70%

Safety Score

1M 6M YTD 1Y 2Y 5Y Max

Loading chart...

DCF Valuation

Tweak assumptions to recompute fair value for Merrimack Pharmaceuticals, Inc. (MACK)

Currency: USD

DCF Assumptions

Revenue growth (YoY) 0.10 Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).

EBITDA margin 0.30 Decimal (e.g., 0.30 = 30%).

Capex (% Revenue) 0.04 Decimal (e.g., 0.04 = 4%).

Tax rate 0.20 Decimal (e.g., 0.20 = 20%).

Terminal growth (g, %) 3% Percent number (e.g., 3 = 3%).

Cost of Equity (%) 10% Percent number (e.g., 10 = 10%).

Cost of Debt (%) 5% Percent number (e.g., 5 = 5%).

DCF Result

Fair Value (DCF)

—

Current Price

—

Upside

—

WACC

—

Terminal PV

—

Σ PV of FCFs

—

Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Merrimack Pharmaceuticals, Inc. Analysis (MACK)

United States Health Care Official Website Stock

Is Merrimack Pharmaceuticals, Inc. a good investment? Merrimack Pharmaceuticals, Inc. (MACK) is currently trading at 15.15 USD.

For income investors, Merrimack Pharmaceuticals, Inc. pays a dividend yield of 99.70%.

Investor FAQ

Does Merrimack Pharmaceuticals, Inc. pay a dividend?

Yes, it pays an annual dividend of 15.10 USD (99.70% yield).

What asset class is Merrimack Pharmaceuticals, Inc.?

Merrimack Pharmaceuticals, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

Exchange Ticker

NGM (Sweden) MACK

Trades

Dividend Yield

99.70%

Annual Dividends

15.10USD

Next Ex. Div Date

May 20, 2024

Dividend History paid per year (USD)

Historical Dividends

Year	Total Dividends
▸2024	30.20 USD
May 20, 2024	15.1000
May 17, 2024	15.1000
▸2019	2.00 USD
Dec. 23, 2019	0.5000
Sept. 6, 2019	1.4967
▸2017	1.06 USD
May 30, 2017	1.0552

Stock Splits

Split Date	Split Ratio to 1
Sept. 6, 2017	1:10
Sept. 6, 2019	1.27

Merrimack Pharmaceuticals, Inc. MACK · Stock Open Merrimack Pharmaceuticals, Inc. in new tab

Dividend

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Merrimack Pharmaceuticals, Inc. Analysis (MACK)

Investor FAQ

Company Profile

Fundamentals

Under Construction

Merrimack Pharmaceuticals, Inc. MACK · Stock Open Merrimack Pharmaceuticals, Inc. in new tab

Dividend

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features

Merrimack Pharmaceuticals, Inc. Analysis (MACK)

Investor FAQ

Company Profile

Explore Premium Features

Fundamentals

Under Construction

Community Discussion

Notifications